Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0789
Full Text
Open PDFAbstract
Available in full text
Date
September 26, 2016
Authors
Publisher
American Association for Cancer Research (AACR)